BAFF基因变异与干燥综合征患者淋巴瘤风险相关
该病例对照研究纳入770例干燥综合征(SjD)患者和786名对照,分析BAFF基因功能变异(BAFF-var)与临床表型及淋巴瘤风险的关系。结果发现BAFF-var与更高的可溶性BAFF水平、淋巴瘤发生风险增加以及SjD易感性均显著相关,提示其可能作为SjD淋巴瘤风险的新生物标志物。
要点
- BAFF-var与SjD患者淋巴瘤风险独立相关(OR 2.60,95%CI 1.14-5.47)。
核心结论
- BAFF-var与干燥综合征患者可溶性BAFF水平升高、淋巴瘤发生风险增加及SjD易感性均相关。
- BAFF-var可能成为干燥综合征淋巴瘤风险的新生物标志物。
研究设计与样本
- 病例对照研究,纳入巴黎Saclay和ASSESS队列的770例SjD患者及786名EFS献血者对照。
- 遗传关联分析仅纳入经24个祖源信息标记主成分分析判定为欧洲祖源的666例患者和721名对照。
主要发现
- 调整类风湿因子、性别和累积EULAR Sjögren综合征疾病活动指数后,BAFF-var仍与淋巴瘤独立相关(OR 2.60,95%CI 1.14-5.47)。
关键数值与推荐
- BAFF-var与淋巴瘤关联的OR为2.60(95%CI 1.14-5.47),调整因素包括类风湿因子、性别和累积EULAR Sjögren综合征疾病活动指数。
临床怎么用
- 对干燥综合征患者可考虑检测BAFF-var以辅助评估淋巴瘤风险。
- BAFF-var携带者可能需要更密切的淋巴瘤监测。
局限性
- 遗传关联分析仅纳入欧洲祖源患者,结果外推需谨慎。
- 研究为病例对照设计,BAFF-var作为淋巴瘤风险生物标志物的临床效用尚需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: B-cell activating factor (BAFF) of the Tumors Necrosis Factor (TNF) family is involved in the pathogenesis of Sjögren's disease (SjD). A functional variant (BAFF variant [BAFF-var]) of the BAFF gene (TNFSF13B), leading to increased levels of BAFF, has been described. The aim of this study was to investigate the association between BAFF-var and clinical phenotype and risk of SjD. METHODS: A case-control study including cases from Paris Saclay and the Assessment of Systemic Signs and Evolution in Sjögren's syndrome (ASSESS) cohort and controls (blood donors from Etablissement Français du Sang [EFS]) was conducted. Genetic association analyses included only patients with European ancestry assessed by a principal component analysis using 24 ancestry-informative markers. RESULTS: We included 770 cases (420 from Paris Saclay and 350 from ASSESS) and 786 controls from EFS. Among them, 666 cases and 721 controls were found of European ancestry. We found that BAFF-var was significantly associated with higher soluble BAFF (sBAFF) level (1392.7 vs 1107.0 pg/mL, P < .001), and with increased occurrence of lymphoma (13% in patients with SjD with BAFF-var vs 5.8% in patients with SjD with BAFF-WT (wild-type), P = .013). BAFF-var remained independently associated with lymphoma after adjustment for rheumatoid factor, sex, and cumulative European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (odds ratio [OR] 2.60, 95% CI: 1.14-5.47). By comparison with ancestry-matched controls, BAFF-var was also associated with SjD itself with a minor allele frequency of 0.061 in cases and 0.035 in controls (OR = 1.77, P = .0017). CONCLUSIONS: We found an association between BAFF-var and sBAFF levels, occurrence of lymphoma as well as occurrence of SjD itself. This variant could be a new biomarker for lymphoma risk in SjD.
引用
- Beydon M, Dulin M, Ly B, et al. A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease. Ann Rheum Dis. 2026. PMID: 41539891. doi:10.1016/j.ard.2025.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。